Evaluation of a Phosphate Management Protocol to Achieve Optimum Serum Phosphate Levels in Hemodialysis Patients [PDF]
, 2008 Original article can be found at: http://www.sciencedirect.com/science/journal/10512276 Copyright National Kidney Foundation, Inc. DOI: 10.1053/j.jrn.2008.05.003To evaluate the effectiveness of a protocol designed to optimize serum phosphate levels in ...
Cheung, C.F. +5 more
core +1 more source
Validation of a novel scoring system for changes in skeletal manifestations of hypophosphatasia in newborns, infants, and children: The Radiographic Global Impression of Change scale [PDF]
, 2018 Hypophosphatasia (HPP) is the heritable metabolic disease characterized by impaired skeletal mineralization due to low activity of the tissue-nonspecific isoenzyme of alkaline phosphatase.
Fujita, Kenji P +4 more
core +2 more sources
Targeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia.
New England Journal of Medicine, 2020 Targeted FGFR Blockade for Tumor-Induced Osteomalacia This letter describes the treatment of a patient with tumor-induced osteomalacia due to a phosphaturic mesenchymal tumor.
Iris R. Hartley +13 more
semanticscholar +1 more source
The case of oncogenic hypophosphatemic osteomalacia
Ожирение и метаболизм, 2020 Osteomalacia is a systemic bone disease, characterized by an excessive accumulation of non-mineralized osteoid and an imbalance in the organic matrix formation and mineralization.
Anna K. Eremkina +5 more
doaj +1 more source
Tumor-induced osteomalacia – a mystery illness beyond aches, pains, and depression
Endocrine Regulations, 2021 Objective. Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by chronic hypophosphatemia and osteomalacia. We present case of a patient with a protracted clinical course of TIO.
Ni Huajing (Jing) +2 more
doaj +1 more source
Journal of Bone and Mineral Research, 2019 In adults with X‐linked hypophosphatemia (XLH), excess FGF23 impairs renal phosphate reabsorption and suppresses production of 1,25‐dihydroxyvitamin D, resulting in chronic hypophosphatemia and persistent osteomalacia.
K. Insogna +9 more
semanticscholar +1 more source
Journal of Cancer Research and Therapeutics, 2009 Oncogenous osteomalacia is a rare paraneoplastic renal phosphaturic condition, often associated with highly vascular benign mesenchymal tumors. We report a case of a 48-year-old male who presented with debilitating osteomalacia unresponsive to standard therapy.
Ghosh, Soumitra +3 more
openaire +2 more sources
Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use
Infectious Disease Reports, 2021 Tenofovir disoproxil fumarate (TDF) is used worldwide to treat and prevent Human Immunodeficiency Virus (HIV) infection. Fanconi syndrome is a complication of TDF use and is characterized by inadequate reabsorption of glucose, phosphate and protein in ...
Mana Rao +3 more
doaj +1 more source
Bisphosphonate‐Induced Deterioration of Osteomalacia in Undiagnosed Adult Fanconi Syndrome
JBMR Plus, 2020 We describe two women with a misdiagnosed fracturing bone disease who were treated erroneously with i.v. zoledronate. Over the next year, they suffered marked clinical and radiographic deterioration in skeletal disease.
T. Cundy, L. Que, I. Hassan, L. Hughes
semanticscholar +1 more source
A feasibility study of educational tools for osteomalacia [PDF]
, 2016 Many people in the UK, particularly people of South Asian origin, are advised to supplement their vitamin D intake, yet most do not. This suggests an unmet educational need. The osteomalacia mind map was developed to meet this need. The mind map contains
A Adebajo +33 more
core +4 more sources